Login
Super Investors Tetragon Partners GP Ltd
TP

Tetragon Partners GP Ltd

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$766M
Positions
37
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (54 quarters reported)

$2.2B $9.24M
Q2 13 Q1 16 Q4 18 Q3 21 Q2 24 Q3 26

$141M in Q2 2013 → $766M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Uipath Inc 54.5% Added 5.0% 32,500,000 $417M
Kolibri Global Energy Inc 5.5% Unchanged 6,834,504 $42.3M
Silence Therapeutics PLC 3.5% Added 219% 2,436,051 $26.6M
PN Pharvaris Nv 3.5% Added 184% 838,247 $26.6M
Ionis Pharmaceuticals Inc 2.6% Added 354% 440,930 $19.7M
Autolus Therapeutics Ltd 2.4% Unchanged 9,500,000 $18.4M
AP Arrowhead Pharmaceuticals In 2.3% Added 102% 264,040 $17.3M
Lyft Inc 2.0% Unchanged 1,000,000 $15M
Workiva Inc 2.0% Trimmed 10% 225,000 $15M
Mbx Biosciences Inc 1.7% Added 8.4% 220,647 $12.9M
Definium Therapeutics Inc 1.5% Added 8.3% 310,892 $11.8M
Sprinklr Inc 1.4% Unchanged 2,200,000 $10.9M
CT Celldex Therapeutics Inc New 1.3% Added 1.9% 295,941 $9.59M
Immunovant Inc 1.2% Added 7.5% 275,219 $9.3M
HB Harmony Biosciences Hldgs In 1.2% Added 13% 226,677 $8.9M
Alkami Technology Inc 1.2% Added 8.3% 650,000 $8.9M
Alkermes PLC 1.1% Added 8.8% 206,778 $8.38M
Dyne Therapeutics Inc 1.1% Added 43% 511,280 $8.24M
Relay Therapeutics Inc 1.1% Trimmed 22% 447,235 $8.07M
Agios Pharmaceuticals Inc 0.9% Added 4.8% 215,529 $7.17M
Celcuity Inc 0.9% Added 36% 87,421 $6.95M
Neurocrine Biosciences Inc 0.9% New 47,014 $6.67M
Krystal Biotech Inc 0.9% Unchanged 19,668 $6.54M
Axsome Therapeutics Inc. 0.8% New 35,000 $6.45M
Warner Bros Discovery Inc 0.8% Trimmed 20% 200,000 $6.19M
Nektar Therapeutics 0.8% Added 17% 101,645 $6.15M
Silence Therapeutics PLC Call 0.7% Added 67% 500,000 $5.47M
Uber Technologies Inc 0.6% New 71,428 $4.89M
Snowflake Inc 0.4% Unchanged 10,000 $3.4M
An2 Therapeutics Inc 0.4% New 603,424 $3.21M
Annexon Inc 0.4% Trimmed 47% 655,948 $2.77M
Agios Pharmaceuticals Inc Call 0.2% Unchanged 50,000 $1.66M
Monte Rosa Therapeutics Inc Call 0.2% New 100,000 $1.19M
Monte Rosa Therapeutics Inc 0.1% Unchanged 56,052 $669K
Tectonic Therapeutic Inc 0.1% Trimmed 42% 26,798 $624K
Sol-gel Technologies Ltd 0.1% New 8,307 $617K
Tenax Therapeutics Inc Call 0.0% Unchanged 75,100 $142K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
Uipath Inc Added +1,550,000 +$19.9M 54.5%
Silence Therapeutics PLC Added +1,671,795 +$18.3M 3.5%
PN Pharvaris Nv Added +542,620 +$17.2M 3.5%
Ionis Pharmaceuticals Inc Added +343,757 +$15.3M 2.6%
AP Arrowhead Pharmaceuticals In Added +133,556 +$8.74M 2.3%
Axsome Therapeutics Inc. Exited −35,000 −$8.57M —
Neurocrine Biosciences Inc New +47,014 +$6.67M 0.9%
Axsome Therapeutics Inc. New +35,000 +$6.45M 0.8%
Amylyx Pharmaceuticals Inc Exited −297,926 −$5.35M —
Uber Technologies Inc New +71,428 +$4.89M 0.6%

Showing the 10 largest of 36 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 13, 2026

Company Action Shares changed Value of change % of portfolio
Uipath Inc Added +5,742,372 +$62.4M 53.0%
Warner Bros Discovery Inc Trimmed −673,725 −$18M 1.0%
Alkami Technology Inc New +600,284 +$10.9M 1.7%
Relay Therapeutics Inc Added +388,768 +$7.27M 1.7%
Celcuity Inc New +64,110 +$6.71M 1.1%
PP Praxis Precision Medicines I Exited −15,952 −$5.14M —
Ionis Pharmaceuticals Inc Added +55,409 +$4.39M 1.2%
Definium Therapeutics Inc Added +86,996 +$4.09M 2.1%
Soleno Therapeutics Inc Exited −102,125 −$3.42M —
Axsome Therapeutics Inc. Exited −20,059 −$3.39M —

Showing the 10 largest of 38 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
Uipath Inc Added +7,757,628 +$86.1M 54.3%
Warner Bros Discovery Inc New +923,725 +$25.4M 4.9%
Workiva Inc Added +100,000 +$5.96M 2.9%
Axsome Therapeutics Inc. New +35,000 +$5.92M 1.1%
Rapt Therapeutics Inc Exited −131,770 −$4.46M —
Annexon Inc Trimmed −740,000 −$4.1M 1.4%
Definium Therapeutics Inc New +199,994 +$3.78M 0.7%
Amicus Therapeutics Inc Exited −260,771 −$3.71M —
Soleno Therapeutics Inc New +102,125 +$3.42M 0.7%
Acadia Pharmaceuticals Inc New +144,620 +$3.22M 0.6%

Showing the 10 largest of 36 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
AG Alibaba Group Hldg Ltd Exited −95,000,000 −$175M —
IT Ishares Tr Exited −726,900 −$59M —
Lithium Argentina Ag Exited −27,109,000 −$24.6M —
Cable One Inc Exited −21,255,000 −$20.8M —
Progress Software Corp Exited −20,500,000 −$20.6M —
Oatly Group Ab Exited −20,020,027 −$18.4M —
Uipath Inc Added +500,000 +$8.2M 60.3%
First Majestic Silver Corp Exited −7,500,000 −$7.97M —
Celcuity Inc Exited −5,550,000 −$7.44M —
Tarsus Pharmaceuticals Inc Exited −125,000 −$7.43M —

Showing the 10 largest of 47 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
Uipath Inc Added +3,227,756 +$43.2M 30.3%
Jd.com Inc Exited −20,000,000 −$20.9M —
Cable One Inc New +21,255,000 +$20.8M 2.8%
Progress Software Corp New +20,500,000 +$20.6M 2.8%
Trip Com Group Ltd Exited −10,000,000 −$11.1M —
Lithium Argentina Ag Added +10,500,000 +$9.51M 3.3%
AG Alibaba Group Hldg Ltd Trimmed −5,000,000 −$9.2M 23.4%
IT Ishares Tr Trimmed −95,100 −$7.72M 7.9%
Celcuity Inc New +5,550,000 +$7.44M 1.0%
Tarsus Pharmaceuticals Inc Trimmed −125,000 −$7.43M 1.0%

Showing the 10 largest of 41 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
AG Alibaba Group Hldg Ltd New +100,000,000 +$128M 20.6%
IT Ishares Tr Trimmed −779,900 −$62.9M 10.7%
Uipath Inc Added +4,772,244 +$61.1M 28.3%
Jd.com Inc New +20,000,000 +$20.9M 3.4%
Informatica Inc Exited −800,000 −$14M —
Trip Com Group Ltd New +10,000,000 +$11.1M 1.8%
Workiva Inc New +150,000 +$10.3M 1.7%
First Majestic Silver Corp Trimmed −9,000,000 −$8.74M 1.2%
Lithium Argentina Ag Trimmed −6,700,000 −$5.68M 2.3%
SM Ssr Mining In Exited −4,000,000 −$4.08M —

Showing the 10 largest of 34 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Added +610,100 +$48.1M 28.8%
Uipath Inc Added +2,000,000 +$20.6M 21.0%
SM Ssr Mining In Trimmed −16,000,000 −$16.3M 0.9%
BA Bigbear Ai Hldgs Inc Exited −900,000 −$4.01M —
MP Medical Pptys Trust Inc Exited −902,500 −$3.56M —
Informatica Inc Added +200,000 +$3.49M 3.2%
Tectonic Therapeutic Inc New +187,500 +$3.32M 0.8%
Annexon Inc Added +1,250,000 +$2.41M 1.2%
Immunovant Inc New +131,167 +$2.24M 0.5%
IT Ishares Tr Trimmed −27,185 −$2.14M 1.1%

Showing the 10 largest of 26 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 21, 2025

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Added +531,800 +$41.8M 19.9%
Tarsus Pharmaceuticals Inc Trimmed −414,117 −$22.9M 2.8%
First Majestic Silver Corp Trimmed −22,920,000 −$20.8M 3.6%
Informatica Inc Added +200,000 +$5.19M 4.0%
CT Celldex Therapeutics Inc New New +192,000 +$4.85M 1.2%
Ballys Corporation Exited −278,493 −$4.8M —
BA Bigbear Ai Hldgs Inc New +900,000 +$4.01M 1.0%
Axsome Therapeutics Inc New +41,250 +$3.49M 0.9%
Oatly Group Ab Added +4,645,432 +$3.44M 3.6%
Annexon Inc Added +615,645 +$3.16M 1.8%

Showing the 10 largest of 20 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support